The impact of single gene testing (SGT) on subsequent comprehensive genomic profiling (CGP) success in community oncology practice for advanced non-small cell lung cancer (NSCLC): Results from a prospective observational reference laboratory testing program

被引：0
|
作者：
Nesline, Mary K.
DePietro, Paul
Cooper, Maureen
Zhang, Shengle
Howarth, Sarah
Wallen, Zachary D.
Biorn, Michael D.
Strickland, Kyle C.
Previs, Rebecca A.
Ko, Heidi Chwan
Sausen, Mark
Jackson, Jennifer B.
Saini, Kamal S.
Wise, Scott
Jensen, Taylor J.
Pabla, Sarabjot
Conroy, Jeffrey M.
Reddy, Prasanth
Severson, Eric A.
Ramkissoon, Shakti
机构：
[1] Labcorp Oncol, Durham, NC USA
[2] Labcorp Oncol, Buffalo, NY USA
[3] Labcorp, Buffalo, NY USA
[4] Duke Univ, Duke Canc Inst, Dept Pathol, Med Ctr, Durham, NC USA
[5] Duke Univ, Duke Canc Inst, Div Gynecol Oncol, Dept Obstet & Gynecol,Med Ctr, Durham, NC USA
[6] Personal Genome Diagnost, Labcorp, Baltimore, MD USA
[7] LabCorp, Ann Arbor, MI USA
[8] OmniSeq, Labcorp, Buffalo, NY USA
[9] OmniSeq Inc, Labcorp, Buffalo, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6506
引用
收藏
页数：1
相关论文
共 35 条
  • [1] Performance of comprehensive genomic profiling (CGP) versus single gene testing (SGT) in guideline-recommended biomarker selection in non-small cell lung cancer (NSCLC)
    Subbiah, Vivek
    Vasudevan, Anupama
    Roos, Alison
    Schnettler, Erica
    Sathyan, Pratheesh
    Aton, Lindsay
    Varughese, Prateesh
    Blanc, Simon
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] The Impact of Prior Single-Gene Testing on Comprehensive Genomic Profiling Results for Patients with Non-Small Cell Lung Cancer
    Nesline, Mary K.
    Subbiah, Vivek
    Previs, Rebecca A.
    Strickland, Kyle C.
    Ko, Heidi
    Depietro, Paul
    Biorn, Michael D.
    Cooper, Maureen
    Wu, Nini
    Conroy, Jeffrey
    Pabla, Sarabjot
    Zhang, Shengle
    Wallen, Zachary D.
    Sathyan, Pratheesh
    Saini, Kamal
    Eisenberg, Marcia
    Caveney, Brian
    Severson, Eric A.
    Ramkissoon, Shakti
    ONCOLOGY AND THERAPY, 2024, 12 (02) : 329 - 343
  • [3] Case report: Single gene testing and comprehensive genomic profiling in non-small cell lung cancer-a case series of divergent results from a large reference laboratory
    Strickland, Kyle C.
    Nesline, Mary K.
    Previs, Rebecca A.
    Ko, Heidi
    Cooper, Maureen
    Rushton, Jennifer R.
    Wallen, Zachary D.
    Pabla, Sarabjot
    Conroy, Jeffrey M.
    Sausen, Mark
    Saini, Kamal S.
    Cantini, Luca
    Jensen, Taylor J.
    Caveney, Brian J.
    Eisenberg, Marcia
    Severson, Eric A.
    Ramkissoon, Shakti
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [4] Access to Genomic Testing and Targeted Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC): A Single-Institution Study
    Freile, Berenice
    Enrico, Diego
    Tsou, Florencia
    Waisberg, Federico
    Rodriguez, Andres
    Pombo, Teresa
    Mendoza, Andrea
    Salanova, Ruben
    Chacon, Matias
    Pupareli, Carmen Sofia
    Martin, Claudio
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : S10 - S11
  • [5] Comprehensive genomic profiling (CGP) versus conventional molecular diagnostic testing of patients with advanced non-small cell lung cancer (NSCLC): Overall survival (OS) and cost in a US health plan population.
    Signorovitch, James
    Zhou, Zhou
    Ryan, Jason
    Chawla, Anita
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [6] A Paradigm Shift in Non-Small-Cell Lung Cancer (NSCLC) Diagnostics: From Single Gene Tests to Comprehensive Genomic Profiling
    Zameer, Ushna
    Shaikh, Wajiha
    Khan, Abdul Moiz
    CANCER INFORMATICS, 2024, 23
  • [7] Impact of Comprehensive Genome Profiling on the Management of Advanced Non-Small Cell Lung Cancer: Preliminary Results From the Lung Cancer Cohort of the FPG500 Program
    Vitale, Antonio
    Mastrantoni, Luca
    Russo, Jacopo
    Giacomini, Flavia
    Giannarelli, Diana
    Duranti, Simona
    Vita, Emanuele
    Nero, Camilla
    D'Argento, Ettore
    Pasciuto, Tina
    Giaco, Luciano
    Di Salvatore, Mariantonietta
    Panfili, Arianna
    Stefani, Alessio
    Cancellieri, Alessandra
    Lococo, Filippo
    De Paolis, Elisa
    Livi, Vanina
    Daniele, Gennaro
    Trisolini, Rocco
    Minucci, Angelo
    Margaritora, Stefano
    Lorusso, Domenica
    Normanno, Nicola
    Scambia, Giovanni
    Tortora, Giampaolo
    Bria, Emilio
    JCO PRECISION ONCOLOGY, 2024, 8
  • [8] Real-world costs and outcomes associated with biomarker testing by comprehensive genomic profiling (CGP) and non-CGP approaches among patients with metastatic non-small cell lung cancer (mNSCLC)
    Byfield, Stacey DaCosta
    Bapat, Bela
    Becker, Laura
    Reyes, Carolina
    Chatzitheofilou, Ismini
    Hostin, Damon
    Schroeder, Brock
    Fox, John Leonard
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [9] Health and Budget Impact of Liquid-Biopsy-Based Comprehensive Genomic Profile (CGP) Testing in Tissue-Limited Advanced Non-Small Cell Lung Cancer (aNSCLC) Patients
    Patel, Yuti P.
    Husereau, Donald
    Leighl, Natasha B.
    Melosky, Barbara
    Nam, Julian
    CURRENT ONCOLOGY, 2021, 28 (06) : 5278 - 5294
  • [10] Actionability of comprehensive genomic profiling (CGP) compared to single-gene and small panels in patients with advanced/metastatic non-small cell lung cancer (aNSCLC): A real-world study.
    Bapat, Bela
    Sweetnam, Connor
    McBratney, Ashleigh
    Izano, Monika A.
    Schroeder, Brock
    Walters, Sheetal
    Chen, William
    Febbo, Phillip G.
    Berry, Anna B.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
1234